Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16

Clin Vaccine Immunol. 2007 Mar;14(3):281-7. doi: 10.1128/CVI.00404-06. Epub 2007 Jan 31.

Abstract

Hookworm infection is one of most important parasitic infection of humans, occurring in 740 million people. Here we report the protective vaccination of dogs with Ac-16, an immunodominant surface antigen from the hookworm Ancylostoma caninum. We show that immunization with Ac-16 formulated with AS03 elicited specific humoral and cellular immune responses and provided partial protection against hookworm infection and morbidity as evidenced by a significant reduction of hookworm egg counts (64% reduction; P = 0.0078) and worm-induced blood loss (P < 0.05). Moreover, specific anti-Ac-16 antibodies recognized the native protein on the surface of third-stage larvae and blocked their migration through tissue in vitro. Our data support the use of Ac-16 as a potential candidate for vaccination against hookworm infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Ancylostoma / immunology*
  • Anemia / prevention & control*
  • Animals
  • Antibodies, Helminth / blood
  • Cell Proliferation
  • Cloning, Molecular
  • Cytokines / biosynthesis
  • Dogs
  • Female
  • Helminth Proteins / genetics
  • Helminth Proteins / immunology*
  • Hookworm Infections / prevention & control*
  • Male
  • Molecular Sequence Data
  • Parasite Egg Count
  • Vaccination
  • Vaccines, Synthetic / immunology*

Substances

  • Antibodies, Helminth
  • Cytokines
  • Helminth Proteins
  • Vaccines, Synthetic

Associated data

  • GENBANK/DQ445995